|1.||Sweeney, W Brian: 1 article (12/2014)|
|2.||McCarter, Martin D: 1 article (12/2014)|
|3.||Beck, David E: 1 article (12/2014)|
|4.||Ipamorelin 201 Study Group: 1 article (12/2014)|
|5.||Mann, William: 1 article (06/2009)|
|6.||Venkova, Kalina: 1 article (06/2009)|
|7.||Greenwood-Van Meerveld, Beverley: 1 article (06/2009)|
|8.||Nelson, Richard: 1 article (06/2009)|
|9.||Jansson, J O: 1 article (01/2001)|
|10.||Dickson, S L: 1 article (01/2001)|
06/01/2009 - "Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus."
12/01/2014 - "This proof-of-concept, phase 2, randomized study evaluated the safety and efficacy of the ghrelin-receptor agonist ipamorelin in the treatment of postoperative ileus following abdominal surgery (ClinicalTrials.gov NCT00672074). "
12/01/2014 - "Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients."
06/01/2009 - "The present study investigates whether ipamorelin, a selective growth hormone secretagogue and agonist of the ghrelin receptor, would accelerate gastrointestinal transit and ameliorate the symptoms in a rodent model of postoperative ileus (POI). "
|2.||Body Weight (Weight, Body)
06/01/2009 - "In contrast, repetitive dosing of ipamorelin (0.1 or 1 mg/kg) significantly increased the cumulative fecal pellet output, food intake, and body weight gain. "
01/12/2001 - "Ipamorelin also increased fat pad weights relative to body weight in both lit/lit and +/lit mice. "
01/12/2001 - "In +/lit and lit/lit mice ipamorelin induced a small (15%) increase in body weight by 2 weeks, that was not further augmented by 9 weeks. "
04/01/1999 - "With the objective of investigating the effects on longitudinal bone growth rate (LGR), body weight (BW), and GH release, ipamorelin in different doses (0, 18, 90 and 450 microg/day) was injected s.c. "
06/01/2009 - "Compared with the vehicle, a single dose of ipamorelin (1 mg/kg) or GHRP-6 (20 microg/kg) decreased the time to the first bowel movement but had no effect on cumulative fecal output, food intake, or body weight gain measured 48 h after the surgery. "
|3.||Growth Hormone (Somatotropin)
|4.||growth hormone releasing hexapeptide